×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Worldwide schedules comment Share
8076 views

Animateurs:

  • Dr Gwenaël Ferron, chirurgien oncologue Institut Universitaire du Cancer Toulouse
  • Coralie Marjollet, Imagyn

La Société Française de Chirurgie Oncologique s’associe à l’association IMAGYN pour un webinar ONCOSTREAM sur les Tumeurs Rares de l'Ovaire à destination des patientes et des professionnels de santé.

Quelques exemples des thèmes qui seront abordés lors de cette réunion interactive entre oncologues experts du groupe GINECO, spécialistes de soins de support et les patientes :

  • Qu'est-ce qu'une tumeur rare de l'ovaire ?
  • Pourquoi cela touche des femmes jeunes voire des adolescentes ?
  • Quels sont les traitements proposés et pourquoi ?
  • Comment prévenir et prendre en charge les séquelles de traitements, en particulier la fertilité, la ménopause, la sexualité ?
  • Comment accompagner au mieux les patientes et leurs familles? Place de l'association de patientes IMAGYN
  • Quel est le rôle du réseau de centres experts TMRO ?

Afin de pouvoir poser vos questions en direct aux intervenants un chat sera mis à votre disposition.

Shooting date : 2021-05-10
Last update : 2024-02-13
1 comment
Join the Discussion
  • Lauriane G. merci pour la presentation

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)


    Suggestions

    Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
    Honolulu : Wednesday, January 8th 2025 from 06:30am to 07:45am (GMT+1)
    San Francisco : Wednesday, January 8th 2025 from 08:30am to 09:45am (GMT+1)
    New York : Wednesday, January 8th 2025 from 11:30am to 12:45pm (GMT+1)
    Buenos Aires : Wednesday, January 8th 2025 from 01:30pm to 02:45pm (GMT+1)
    London / Dublin : Wednesday, January 8th 2025 from 04:30pm to 05:45pm (GMT+1)
    Paris / Berlin : Wednesday, January 8th 2025 from 05:30pm to 06:45pm (GMT+1)
    Istanbul : Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 8th 2025 from 08:30pm to 09:45pm (GMT+1)
    Bangkok : Wednesday, January 8th 2025 from 11:30pm to 12:45am (GMT+1)
    Shanghai : Thursday, January 9th 2025 from 12:30am to 01:45am (GMT+1)
    Tokyo : Thursday, January 9th 2025 from 01:30am to 02:45am (GMT+1)
    Sydney : Thursday, January 9th 2025 from 02:30am to 03:45am (GMT+1)
    Wellington : Thursday, January 9th 2025 from 04:30am to 05:45am (GMT+1)

    Bénéfices de la maintenance par iPARP en 1L du cancer de l’ovaire

    Share
    Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
    Honolulu : Friday, March 21st 2025 from 02am to 06:30am (GMT+1)
    San Francisco : Friday, March 21st 2025 from 04am to 08:30am (GMT+1)
    New York : Friday, March 21st 2025 from 07am to 11:30am (GMT+1)
    Buenos Aires : Friday, March 21st 2025 from 09am to 01:30pm (GMT+1)
    London / Dublin : Friday, March 21st 2025 from 12pm to 04:30pm (GMT+1)
    Paris / Berlin : Friday, March 21st 2025 from 01pm to 05:30pm (GMT+1)
    Istanbul : Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
    Moscou / Dubaï : Friday, March 21st 2025 from 04pm to 08:30pm (GMT+1)
    Bangkok : Friday, March 21st 2025 from 07pm to 11:30pm (GMT+1)
    Shanghai : Friday, March 21st 2025 from 08pm to 12:30am (GMT+1)
    Tokyo : Friday, March 21st 2025 from 09pm to 01:30am (GMT+1)
    Sydney : Friday, March 21st 2025 from 10pm to 02:30am (GMT+1)
    Wellington : Saturday, March 22nd 2025 from 12am to 04:30am (GMT+1)

    Transpyrenean Oncogynae Symposium

    Advancing gynecologic oncology: from molecular insights to clinical practice

    Share
    Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, October 10th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, October 10th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, October 10th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, October 10th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, October 10th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, October 11th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, October 11th 2023 from 05:30am to 07am (GMT+2)

    La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

    Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

    Share
    Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Thursday, March 14th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Thursday, March 14th 2024 from 08am to 09:30am (GMT+1)
    New York : Thursday, March 14th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Thursday, March 14th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Thursday, March 14th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Thursday, March 14th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Thursday, March 14th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
    Sydney : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
    Wellington : Friday, March 15th 2024 from 04am to 05:30am (GMT+1)

    Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

    Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

    Share
    Scroll Up